A Michael Lincoff Selected Research

Antithrombins

5/2008	Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
6/2007	Association of prerandomization anticoagulant switching with bleeding in the setting of percutaneous coronary intervention (A REPLACE-2 analysis).
3/2007	Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial.
12/2005	Bivalirudin vs heparin in percutaneous coronary intervention: a pooled analysis.
10/2003	Direct thrombin inhibitors for non-ST-segment elevation acute coronary syndromes: what, when, and where?
2/2003	Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial.
5/2002	Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Michael Lincoff Research Topics

Disease

68	Myocardial Infarction 04/2024 - 05/2002
65	Hemorrhage 01/2023 - 05/2002
50	Acute Coronary Syndrome 02/2024 - 08/2003
35	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 04/2002
28	Stroke (Strokes) 04/2024 - 03/2006
23	Thrombosis (Thrombus) 03/2024 - 05/2002
20	Coronary Artery Disease (Coronary Atherosclerosis) 04/2024 - 08/2003
20	ST Elevation Myocardial Infarction 01/2022 - 07/2002
18	Type 2 Diabetes Mellitus (MODY) 01/2024 - 09/2007
16	Ischemia 01/2019 - 07/2002
13	Unstable Angina 10/2022 - 06/2003
11	Inflammation (Inflammations) 11/2023 - 03/2002
11	Vascular Diseases (Vascular Disease) 10/2022 - 09/2007
10	Diabetes Mellitus 02/2024 - 06/2004
8	Heart Failure 01/2024 - 08/2003
7	Hypogonadism (Hypergonadotropic Hypogonadism) 02/2024 - 01/2022
7	Anemia 10/2023 - 07/2004
7	Infarction (Infarctions) 11/2020 - 07/2002
6	Obesity 05/2024 - 11/2020
6	Coronary Disease (Coronary Heart Disease) 01/2018 - 05/2002
6	Hyperplasia 04/2006 - 04/2002
5	Overweight 05/2024 - 11/2020
5	Chronic Renal Insufficiency 01/2023 - 05/2002
5	Rheumatoid Arthritis 01/2018 - 04/2009
5	Osteoarthritis 01/2018 - 04/2009
5	Atherosclerosis 01/2014 - 08/2005
5	Vascular System Injuries 08/2005 - 10/2002
4	Hypersensitivity (Allergy) 04/2024 - 06/2008
4	Thrombocytopenia (Thrombopenia) 06/2008 - 11/2004
3	Weight Loss (Weight Reduction) 05/2024 - 04/2008
3	Atrial Fibrillation 01/2024 - 06/2008
3	Gout 11/2023 - 04/2023
3	Cholelithiasis 11/2023 - 04/2023
3	Heart Diseases (Heart Disease) 01/2023 - 03/2008
3	Atherosclerotic Plaque (Atheroma) 01/2021 - 05/2002
3	Peripheral Arterial Disease 01/2021 - 10/2006
3	Arthritis (Polyarthritis) 11/2017 - 04/2009
3	Non-ST Elevated Myocardial Infarction 02/2015 - 08/2003
3	Renal Insufficiency (Renal Failure) 02/2009 - 04/2002

Drug/Important Bio-Agent (IBA)

45	bivalirudin (Angiomax)FDA Link 01/2018 - 05/2002
43	Heparin (Liquaemin)FDA LinkGeneric 01/2018 - 05/2002
28	Glycoproteins (Glycoprotein)IBA 01/2018 - 07/2002
15	Platelet Membrane Glycoprotein IIbIBA 02/2016 - 02/2003
13	Clopidogrel (Plavix)FDA Link 11/2014 - 07/2006
12	aleglitazarIBA 01/2022 - 07/2009
12	Abciximab (ReoPro)FDA Link 10/2007 - 04/2002
10	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2024 - 10/2018
10	evacetrapibIBA 10/2022 - 12/2015
9	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022 - 07/2009
9	AnticoagulantsIBA 01/2020 - 05/2002
9	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016 - 07/2006
8	Hemoglobins (Hemoglobin)IBA 02/2024 - 01/2003
8	C-Reactive ProteinIBA 01/2024 - 02/2011
8	omega-Chloroacetophenone (Mace)IBA 01/2024 - 02/2011
8	Cholesterol Ester Transfer ProteinsIBA 10/2022 - 12/2015
7	CholesterolIBA 04/2024 - 08/2014
7	Testosterone (Sustanon)FDA Link 02/2024 - 01/2022
7	LipidsIBA 01/2021 - 11/2003
7	Insulin (Novolin)FDA Link 01/2021 - 04/2008
7	AntithrombinsIBA 05/2008 - 05/2002
6	semaglutideIBA 05/2024 - 11/2020
6	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA 01/2024 - 04/2023
6	Celecoxib (Celebrex)FDA Link 01/2018 - 01/2005
6	Enoxaparin (Lovenox)FDA LinkGeneric 09/2008 - 01/2003
5	Apolipoprotein A-I (Apolipoprotein A1)IBA 04/2024 - 10/2016
5	CSL112IBA 04/2024 - 10/2016
5	CreatinineIBA 11/2023 - 10/2003
5	Ibuprofen (Motrin)FDA LinkGeneric 01/2018 - 04/2009
5	Naproxen (Naprosyn)FDA LinkGeneric 01/2018 - 04/2009
5	Platelet Membrane GlycoproteinsIBA 02/2008 - 11/2002
4	Biomarkers (Surrogate Marker)IBA 01/2017 - 03/2007
4	Pioglitazone (Actos)FDA Link 11/2014 - 09/2007
4	MB Form Creatine KinaseIBA 10/2014 - 03/2005
4	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 06/2008 - 11/2006
4	Eptifibatide (Integrilin)FDA Link 02/2008 - 01/2003
4	reteplase FDA Link 10/2007 - 07/2002
3	Proteins (Proteins, Gene)FDA Link 04/2024 - 10/2002
3	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 09/2013
3	oxidized low density lipoproteinIBA 01/2024 - 01/2019
3	EnzymesIBA 11/2023 - 10/2003
3	TicagrelorIBA 01/2023 - 02/2012
3	Prasugrel Hydrochloride FDA Link 01/2023 - 12/2009
3	Lipoprotein(a)IBA 10/2022 - 01/2020
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2017 - 04/2009
3	AntibodiesIBA 12/2016 - 02/2007
3	cangrelorIBA 12/2009 - 02/2003
3	P-SelectinIBA 08/2005 - 07/2002
3	LigandsIBA 05/2003 - 07/2002
2	HDL LipoproteinsIBA 04/2024 - 10/2016
2	pro-brain natriuretic peptide (1-76)IBA 02/2024 - 01/2018

Therapy/Procedure

67	Therapeutics 02/2024 - 01/2002
53	Percutaneous Coronary Intervention 01/2023 - 05/2002
24	Stents 03/2024 - 04/2002
10	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2018 - 12/2002
8	Drug-Eluting Stents 01/2021 - 07/2006
8	Thrombolytic Therapy 10/2014 - 11/2002
6	Blood Transfusion (Blood Transfusions) 06/2011 - 01/2003
5	Glycemic Control 02/2024 - 09/2007
5	Drug Therapy (Chemotherapy) 01/2024 - 02/2009
5	Secondary Prevention 12/2023 - 11/2003